Omipalisib (GSK2126458)

Omipalisib (GSK2126458, GSK458) is a highly selective and potent inhibitor of p110α/β/δ/γ, mTORC1/2 with Ki of 0.019 nM/0.13 nM/0.024 nM/0.06 nM and 0.18 nM/0.3 nM in cell-free assays, respectively. Omipalisib induces autophagy. Phase 1.

Price Not Available 2mg Omipalisib (GSK2126458) Supplier Page

Trivial name	GSK458
Catalog Number	S2658
Molecular Formula	C17H18BrN3O4S
CAS#	1086062-66-9
Inchi	InChI=1S/C17H18BrN3O4S/c1-10-7-11(18)5-6-16(10)26(23,24)19-12-8-13-14(9-15(12)25-4)21(3)17(22)20(13)2/h5-9,19H,1-4H3
Inchi Key	YUNQZQREIHWDQT-UHFFFAOYSA-N
SMILES	CC1=C(C=CC(=C1)Br)S(=O)(=O)NC2=CC3=C(C=C2OC)N(C(=O)N3C)C
Size	2mg
Supplier Page	http://www.selleckchem.com/products/gsk2126458.html
Additional Information	https://file.selleck.cn/downloads/struct/GSK2126458-chemical-structure-s2658.gif